Syncona Portfolio Ltd - Q1 2022 holdings

Add to watchlist

$105 Million is the total value of Syncona Portfolio Ltd's 4 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
ACHL  ACHILLES THERAPEUTICS PLCsponsored ads$55,545,0000.0%11,086,9090.0%53.06%0.0%
AUTL  AUTOLUS THERAPEUTICS PLCspon ads$38,130,0000.0%7,346,8290.0%36.42%0.0%
FRLN BuyFREELINE THERAPEUTICS HLDGSsponsored ads$5,841,0000.0%21,997,620
+645.7%
5.58%0.0%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$5,165,0000.0%1,377,2940.0%4.93%0.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Syncona Holdings Limited #1
  • Syncona Limited #2
  • Syncona Investment Management Limited #3
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-31
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AUTOLUS THERAPEUTICS PLC8Q3 202376.6%
ACHILLES THERAPEUTICS PLC8Q3 202353.1%
FREELINE THERAPEUTICS HLDGS8Q3 202327.4%
ADAPTIMMUNE THERAPEUTICS PLC8Q3 20234.9%

View Syncona Portfolio Ltd's complete holdings history.

Latest significant ownerships (13-D/G)
Syncona Portfolio Ltd Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Freeline Therapeutics Holdings plcMarch 25, 202237,862,14762.3%
Nightstar Therapeutics plcMarch 14, 201913,203,92239.0%

View Syncona Portfolio Ltd's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-02-22
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2024-02-01
SC 13D/A2023-11-24
13F-HR2023-11-01
SC 13D/A2023-10-18
13F-HR2023-07-27
13F-HR2023-05-12
SC 13G/A2023-02-14

View Syncona Portfolio Ltd's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Syncona Portfolio Ltd's holdings

CSVXLS